61 related articles for article (PubMed ID: 581941)
1. Pharmacokinetics of amixetrine in the dog. Relation of dose-to-plasma concentration.
Constantin M; Pognat JF
Arzneimittelforschung; 1978; 28(4):646-51. PubMed ID: 581941
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of bromhexine in the dog.
Vandecasteele-Thienpont LM; Belpaire FM; Braeckman RA; De Leenheer AP
Arzneimittelforschung; 1980; 30(10):1643-5. PubMed ID: 7192102
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of intravenous camazepam in dogs.
Legheand J; Cuisinaud G; Bernard N; Riotte M; Sassard J
Arzneimittelforschung; 1982; 32(7):752-6. PubMed ID: 6127087
[TBL] [Abstract][Full Text] [Related]
4. Analytical determination and pharmacokinetics of robenacoxib in the dog.
Jung M; Lees P; Seewald W; King JN
J Vet Pharmacol Ther; 2009 Feb; 32(1):41-8. PubMed ID: 19161454
[TBL] [Abstract][Full Text] [Related]
5. Urinary metabolites of amixetrine in man and in the dog.
Constatin M; Pognat JF; Streichenberger G
Arzneimittelforschung; 1976; 26(1):80-7. PubMed ID: 947187
[TBL] [Abstract][Full Text] [Related]
6. Gaschromatography of clemastine. A study of plasma kinetics and biological effect.
Tham R; Norlander B; Hägermark O; Fransson L
Arzneimittelforschung; 1978; 28(6):1017-20. PubMed ID: 35180
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and metabolism of zopiclone.
Gaillot J; Heusse D; Hougton GW; Marc Aurele J; Dreyfus JF
Int Pharmacopsychiatry; 1982; 17 Suppl 2():76-91. PubMed ID: 7188377
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of adimolol after single and multiple dose administration in healthy volunteers.
Wiedemann I; Peil H; Justus H; Adamus S; Brantl V; Lohmann H
Arzneimittelforschung; 1985; 35(6):964-9. PubMed ID: 2862877
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and systemic bioavailability of menogaril, an anthracycline antitumor agent, in the mouse, dog, and monkey.
Adams WJ; McGovren JP; Dalm EA; Brewer JE; Hosley JD
Cancer Res; 1989 Nov; 49(22):6328-36. PubMed ID: 2529962
[TBL] [Abstract][Full Text] [Related]
10. Preclinical pharmacokinetics and metabolism of 6-(4-(2,5-difluorophenyl)oxazol-5-yl)-3-isopropyl-[1,2,4]-triazolo[4,3-a]pyridine, a novel and selective p38alpha inhibitor: identification of an active metabolite in preclinical species and human liver microsomes.
Kalgutkar AS; Hatch HL; Kosea F; Nguyen HT; Choo EF; McClure KF; Taylor TJ; Henne KR; Kuperman AV; Dombroski MA; Letavic MA
Biopharm Drug Dispos; 2006 Nov; 27(8):371-86. PubMed ID: 16944451
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of vinpocetine (Cavinton) in dog.
Polgár M; Vereczkey L
Pol J Pharmacol Pharm; 1984; 36(4):407-12. PubMed ID: 6527972
[TBL] [Abstract][Full Text] [Related]
12. Stereoselectivity in the metabolism of disopyramide enantiomers in rat and dog.
Cook CS; Karim A; Sollman P
Drug Metab Dispos; 1982; 10(2):116-21. PubMed ID: 6124395
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and oral bioavailability of pentoxyfylline in broiler chickens.
De Boever S; Baert K; De Backer P; Croubels S
J Vet Pharmacol Ther; 2005 Dec; 28(6):575-80. PubMed ID: 16343291
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of hypoxic cell radiosensitizers: a review.
Workman P
Cancer Clin Trials; 1980; 3(3):237-51. PubMed ID: 7438321
[TBL] [Abstract][Full Text] [Related]
15. [Pharmacokinetics of naltrexone hydrochloride and naltrexone glucuronide in the dog].
Li H; Zhao SF; Wang N; Ge ZH
Yao Xue Xue Bao; 1996; 31(4):254-7. PubMed ID: 9208648
[TBL] [Abstract][Full Text] [Related]
16. Disposition of L-738,167, a potent and long-acting fibrinogen receptor antagonist, in dogs. Dose-dependent pharmacokinetics.
Prueksaritanont T; Gorham LM; Naue JA; Hamill TG; Askew BC; Vyas KP
Drug Metab Dispos; 1997 Mar; 25(3):355-61. PubMed ID: 9172954
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of YM175, a new bisphosphonate, in rats and dogs.
Usui T; Watanabe T; Higuchi S
Drug Metab Dispos; 1995 Nov; 23(11):1214-9. PubMed ID: 8591721
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and disposition of the oxytocin receptor antagonist L-368,899 in rats and dogs.
Thompson KL; Vincent SH; Miller RR; Colletti AE; Alvaro RF; Wallace MA; Feeney WP; Chiu SH
Drug Metab Dispos; 1997 Oct; 25(10):1113-8. PubMed ID: 9321512
[TBL] [Abstract][Full Text] [Related]
19. Dose-independent pharmacokinetics of the cardioprotective agent dexrazoxane in dogs.
Baldwin JR; Lewis RC; Phillips BA; Overmyer SK; Hatfield NZ; Narang PK
Biopharm Drug Dispos; 1996 Aug; 17(6):541-50. PubMed ID: 8866044
[TBL] [Abstract][Full Text] [Related]
20. An investigation of the dose proportionality of deflazacort pharmacokinetics.
Rao N; Bhargava VO; Reynolds DL; Eller MG; Weir SJ
Biopharm Drug Dispos; 1996 Dec; 17(9):753-60. PubMed ID: 8968528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
